- Maintenance treatment in COPD:
- 100mcg/25mcg (1 actuation) OD
- 100mcg/25mcg (1 actuation) OD
- Maintenance treatment in asthma:
- 100mcg/25mcg OR 200mcg/25mcg OD
- Inhalation powder:
- 100mcg/25mcg
- 200mcg/25mcg
- Rinse mouth out with water after use (do not swallow water)
- Not to exceed 1 administration/24 hours
- No need for an additional long-acting beta agonist
- Actuate before use by pumping 2 puffs in the air before use.
- Shake for 5 seconds before each use.
- Prime inhaler again if not used for >7 days
Vilanterol: Long-acting selective beta2-adrenergic agonist (LABA); It works by selectively stimulating beta-2 adrenergic receptors, relaxing airway smooth muscle by stimulating intracellular adenyl cyclase resulting in increased cAMP levels
Fluticasone: Long acting inhaled trifluorinated corticosteroid. It inhibits multiple inflammatory cytokines
- Nasopharyngitis
- Headache
- URI
- Oral candidiasis
- Back pain
- Pneumonia
- Sinusitis
- Bronchitis
- Cough
- Oropharyngeal pain
- Arthralgia
- Hypertension
- Influenza
- Pharyngitis
- Diarrhea
- Peripheral edema
- Fever
- Fractures
- Hypersensitivity to class/components
- Severe hypersensitivity to milk protein
- Status asthmaticus
- Acute asthma
- Acute bronchospasm
- Acute deteriorating COPD
- Desmopressin
- Isocarboxazid
- Tranylcypromine
- Inhaled indacaterol
- Lefamulin
Drug Status
Availability | Prescription only |
Pregnancy | Category C |
Breastfeeding | Can be used |
Schedule | Not controlled |
BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
---|---|---|---|---|---|
Relvar Ellipta | 100mcg/25mcg | Inhalation | 30D | GSK Ltd | GSK Ltd |
Relvar Ellipta | 200mcg/25mcg | Inhalation | 30D | GSK Ltd | GSK Ltd |